Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both ...

New data now show that perioperative systemic therapy with apalutamide can improve outcomes after radical prostatectomy.

By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results ...

There will be approximately 299,010 new cases of prostate cancer diagnosed in 2024, according to the American Cancer Society. Treatments vary, including chemotherapy, hormone therapy, ablative therapy ...

A Chinese surgeon remotely operated a robotic system to remove a prostate tumor from a patient 220 kilometers away. Utilizing ...

Here is how robotic surgeries are paving way for new gen cancer treatment in the country - Read on to know all about it.

As the prostate cancer treatment landscape continues to evolve, understanding the risks and benefits of each approach is critical for patients. Prostate cancer treatment continues to evolve, and ...

Compared with patients receiving hormone therapy alone, patients were nine times more likely to have little to no cancer remaining in the prostate after surgery, with a 20 percent reduction in the ris ...

The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...

Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and ...